Cystic fibrosis transmembrane conductance regulator can export hyaluronan

Pathobiology

Volumn 77, Issue 4, 2010, Pages 200-209

  Schulz, Tobias ^a   Schumacher, Udo ^b   Prante, Christian ^d   Sextro, Wolfgang ^c   Prehm, Peter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CF Centre Hamburg Altona and Clinical Research Hannover   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

ABC transporter; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Extracellular matrix; Hyaluronan

Indexed keywords

HYALURONIC ACID; MULTIDRUG RESISTANCE PROTEIN 5; SMALL INTERFERING RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; ABCC5 PROTEIN, MOUSE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRONCHUS SECRETION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; LUNG FIBROSIS; MOUSE; NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CELL MEMBRANE; CYSTIC FIBROSIS; DEFICIENCY; EPITHELIUM CELL; GENETICS; KNOCKOUT MOUSE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FIBROBLASTS; HYALURONIC ACID; MICE; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77954485569     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000295859     Document Type: Article

References (59)

1. Beck S, Kuhr J, Schutz VV, Seydewitz HH, Brandis M, Greger R, Kunzelmann K: Lack of correlation between CFTR expression, CFTR Cl - currents, amiloride-sensitive Na + conductance, and cystic fibrosis phenotype. Pediatr Pulmonol 1999; 27: 251-259.
2. Caldwell RA, Grubb BR, Tarran R, Boucher RC, Knowles MR, Barker PM: In vivo airway surface liquid Cl- analysis with solid-state electrodes. J Gen Physiol 2002; 119: 3-14.
3. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC: Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-1015.
4. Inglis SK, Wilson SM: Cystic fibrosis and airway submucosal glands. Pediatr Pulmonol 2005; 40: 279-284.
5. Trout L, Townsley MI, Bowden AL, Ballard ST: Disruptive effects of anion secretion inhibitors on airway mucus morphology in isolated perfused pig lung. J Physiol 2003; 549: 845-853.
6. Matsui H, Wagner VE, Hill DB, Schwab UE, Rogers TD, Button B, Taylor RM, Superfine R, Rubinstein M, Iglewski BH, Boucher RC: A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 2006; 103: 18131-18136.
7. Prehm P: Synthesis of hyaluronate in differentiated teratocarcinoma cells: mechanism of chain growth. Biochem J 1983; 211: 191-198. (Pubitemid 13104396)
8. Prehm P: Synthesis of hyaluronate in differentiated teratocarcinoma cells: characterization of the synthase. Biochem J 1983; 211: 181-189. (Pubitemid 13104395)
9. Prehm P: Hyaluronate is synthesized at plasma membranes. Biochem J 1984; 220: 597-600.
10. Prehm P: Biosynthesis of hyaluronan: direction of chain elongation. Biochem J 2006; 398: 469-473.
11. Tlapak-Simmons VL, Kempner ES, Baggenstoss BA, Weigel PH: The active streptococcal hyaluronan synthases (HASs) contain a single HAS monomer and multiple cardiolipin molecules. J Biol Chem 1998; 273: 26100-26109.
12. Pummill PE, Kempner ES, DeAngelis PL: Functional molecular mass of a vertebrate hyaluronan synthase as determined by radiation inactivation analysis. J Biol Chem 2001; 276: 39832-39835.
13. Ouskova G, Spellerberg B, Prehm P: Hyaluronan release from Streptococcus pyogenes : export by an ABC transporter. Glycobiology 2004; 14: 931-938.
14. Prehm P, Schumacher U: Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. Biochem Pharmacol 2004; 68: 1401-1410.
15. Schulz T, Schumacher U, Prehm P: Hyaluronan export by the ABC-transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem 2007; 282: 20999-21004.
16. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, McDonald JA: Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan- mediated transformation of epithelium to mesenchyme. J Clin Invest 2000; 106: 349-360.
17. de Wolf CJ, Yamaguchi H, Van der Heijden I, Wielinga PR, Hundscheid SL, Ono N, Scheffer GL, de Haas M, Schuetz JD, Wijnholds J, Borst P: cGMP transport by vesicles from human and mouse erythrocytes. FEBS J 2007; 274: 439-450.
18. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
19. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, Sugiyama Y: Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol 1998; 53: 1068-1075.
20. Linsdell P, Hanrahan JW: Substrates of multidrug resistance-associated proteins block the cystic fibrosis transmembrane conductance regulator chloride channel. Br J Pharmacol 1999; 126: 1471-1477.
21. Lesyk R, Zimenkovsky B, Subtelna I, Nektegayev I, Kazmirchuk G: Synthesis and antiinflammatory activity of some 2-arylamino- 2-thiazoline-4-ones. Acta Pol Pharm 2003; 60: 457-466.
22. Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC: An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol 1993; 8: 522-529.
23. Gorham SD, Olavesen AH, Dodgson KS: Effect of ionic strength and pH on the properties of purified bovine testicular hyaluronidase. Connect Tissue Res 1975; 3: 17-25.
24. Du J, Eddington N: Determination of the chondroitin sulfate disaccharides in dog and horse plasma by HPLC using chondroitinase digestion, precolumn derivatization, and fluorescence detection. Anal Biochem 2002; 306: 252-258.
25. Okada CY, Rechsteiner M: Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 1982; 29: 33-41.
26. Rechsteiner M: Osmotic lysis of pinosomes. Methods Enzymol 1987; 149: 42-48.
27. Lee G, Delohery TM, Ronai Z, Brandt-Rauf PW, Pincus MR, Murphy RB, Weinstein IB: A comparison of techniques for introducing macromolecules into living cells. Cytometry 1993; 14: 265-270.
28. Ghosh C, Iversen PL: Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers. Antisense Nucleic Acid Drug Dev 2000; 10: 263-274.
29. Chakrabarti R, Pfeiffer NE, Wylie DE, Schuster SM: Incorporation of monoclonal antibodies into cells by osmotic permeabilization: effect on cellular metabolism. J Biol Chem 1989; 264: 8214-8221.
30. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS: Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 2004; 124: 125-137.
31. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS: Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002; 110: 1651-1658.
32. Ma T, Vetrivel L, Yang H, Pedemonte N, Zegarra-Moran O, Galietta LJ, Verkman AS: High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J Biol Chem 2002; 277: 37235-37241.
33. Flezar M, Heisler S: P2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion. J Pharmacol Exp Ther 1993; 265: 1499-1510.
34. Thomas NK, Brown TJ: ABC transporters do not contribute to extracellular translocation of hyaluronan in human breast cancer in vitro. Exp Cell Res 2010;316:1241-1251.
35. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM: Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000; 156: 529-536.
36. Abraham EH, Vos P, Kahn J, Grubman SA, Jefferson DM, Ding I, Okunieff P: Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth. Nat Med 1996; 2: 593-596.
37. Li Y, Li L, Brown TJ, Heldin P: Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 2007; 120: 2557-2567.
38. Nickel V, Prehm S, Lansing M, Mausolf A, Podbielski A, Deutscher J, Prehm P: An ectoprotein kinase of group C streptococci binds hyaluronan and regulates capsule formation. J Biol Chem 1998; 273: 23668-23673.
39. Linsdell P, Hanrahan JW: Adenosine triphosphate- dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. J Gen Physiol 1998; 111: 601-614.
40. Lieb T, Forteza R, Salathe M: Hyaluronic acid in cultured ovine tracheal cells and its effect on ciliary beat frequency in vitro. J Aerosol Med 2000; 13: 231-237.
41. Manzanares D, Monzon ME, Savani RC, Salathe M: Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. Am J Respir Cell Mol Biol 2007; 37: 160-168.
42. Wu R, Wu MM: Effects of retinoids on human bronchial epithelial cells: differential regulation of hyaluronate synthesis and keratin protein synthesis. J Cell Physiol 1986; 127: 73-82.
43. Paul A, Picard J, Mergey M, Veissiere D, Finkbeiner WE, Basbaum CB: Glycoconjugates secreted by bovine tracheal serous cells in culture. Arch Biochem Biophys 1988; 260: 75-84.
44. Monzon ME, Casalino-Matsuda SM, Forteza RM: Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 2006; 34: 141.
45. Baraniuk JN, Shizari T, Sabol M, Ali M, Underhill CB: Hyaluronan is exocytosed from serous, but not mucous cells, of human nasal and tracheobronchial submucosal glands. J Invest Med 1996; 44: 47-52.
46. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, Cohn JA, Wilson JM: Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992; 2: 240-248.
47. Doucet L, Mendes F, Montier T, Delepine P, Penque D, Ferec C, Amaral MD: Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem 2003; 51: 1191-1199.
48. Regnier A, Dannhoffer L, Blouquit-Laye S, Bakari M, Naline E, Chinet T: Expression of cystic fibrosis transmembrane conductance regulator in the human distal lung. Hum Pathol 2007; 39: 368-376.
49. Mergey M, Lemnaouar M, Veissiere D, Perricaudet M, Gruenert DC, Picard J, Capeau J, Brahimi-Horn MC, Paul A: CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. Am J Physiol 1995; 269:L855-L864.
50. Tufvesson E, Aronsson D, Bjermer L: Cysteinyl- leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness. Clin Exp Allergy 2007; 37: 1067-1073.
51. Dentener MA, Vernooy JH, Hendriks S, Wouters EF: Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 2005; 60: 114-119.
52. Sahu SC, Ulsamer AG: Hyaluronic acid: an indicator of pulmonary injury? Toxicol Lett 1980; 5: 283-286.
53. Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stossel TP: Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994; 263: 969-971.
54. Lethem MI, James SL, Marriott C, Burke JF: The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990; 3: 19-23. (Pubitemid 20046657)
55. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tummler B, Lang F, Grassme H, Doring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008; 14: 382-391.
56. Leigh MW, Kylander JE, Yankaskas JR, Boucher RC: Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients. Am J Respir Cell Mol Biol 1995; 12: 605-612.
57. Okada Y, Maeno E, Mori S: Anion channel involved in induction of apoptosis and necrosis. Adv Exp Med Biol 2004; 559: 205-209.
58. Guggino WB: Cystic fibrosis and the salt controversy. Cell 1999; 96: 607-610.
59. Day AJ, De La Motte CA: Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005; 26: 637-643.